Innoviva, Inc. – Trademark Portfolio

Entity Type: 03

Innoviva, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INNOVIVA. The owner is based in Burlingame, CA.

1350 Bayshore Highway

Suite 400

Burlingame, CA 94010

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

INNOVIVA
INNOVIVA
Registered 2015
INNOVIVA
INNOVIVA
Abandoned 2015

Trademark Classifications

Innoviva, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Innoviva, Inc. have?

Innoviva, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Innoviva, Inc. file in?

Innoviva, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 45 (Legal & Security Services), Class 5 (Pharmaceuticals). Class 45 covers legal services; security services for the protection of property and individuals.

What are Innoviva, Inc.'s most well-known trademarks?

Innoviva, Inc.'s registered trademark portfolio includes well-known marks such as INNOVIVA. These are among 1 currently registered trademark in the portfolio.

What is Innoviva, Inc.'s trademark registration success rate?

Innoviva, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.